ENA Respiratory announces a US$3.8M contract extension with the United States Department of Defense (DOD)
Exciting news from portfolio company, ENA Respiratory! They’ve secured an additional US$3.8 million contract from the United States Department of Defense (DOD) to advance the research and development of INNA-051. This funding will support crucial non-clinical toxicology and safety studies, setting the stage for an upcoming seasonal prophylaxis phase 2b trial.
Huge congratulations to the entire team!
For more details, check out the announcement here https://lnkd.in/gTwMNzia